A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity

International Journal for Parasitology

Volumn 43, Issue 3-4, 2013, Pages 253-257

  Leung, Jacqueline M ^a   Loke, P'ng ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Helminth therapy; IL 22; Inflammatory bowel diseases; Microbiota; Mucosal immunity

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; CALGRANULIN A; CALGRANULIN B; INTERLEUKIN 22; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PSORIASIN;

BIOTA; DISEASE TREATMENT; HOMEOSTASIS; HOST-PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNITY; PARASITE; PATHOGEN;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CLINICAL TRIAL (TOPIC); COMMENSAL; CYTOKINE PRODUCTION; ENTERITIS; GAMMA DELTA T LYMPHOCYTE; HELMINTHIASIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA; LYMPHOID TISSUE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NECATOR AMERICANUS; NONHUMAN; PERMEABILITY BARRIER; PROTEIN EXPRESSION; REVIEW; RUMINOCOCCUS; THERAPY WITH HELMINTHS; TRICHURIS SUIS; TRICHURIS TRICHIURA; ULCERATIVE COLITIS; WORM EXPULSION;

ANIMALS; HELMINTHS; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKINS; INTESTINES; METAGENOME;

MAMMALIA; NEMATODA; VERMES;

EID: 84873712993     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.10.015     Document Type: Review

References (60)

1. Aggarwal S., Xie M.H., Maruoka M., Foster J., Gurney A.L. Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 2001, 21:1047-1053.
2. Allen J.E., Wynn T.A. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog. 2011, 7:e1002003.
3. Anthony R.M., Rutitzky L.I., Urban J.F., Stadecker M.J., Gause W.C. Protective immune mechanisms in helminth infection. Nat. Rev. 2007, 7:975-987.
4. Artis D., Grencis R.K. The intestinal epithelium: sensors to effectors in nematode infection. Mucosal Immunol. 2008, 1:252-264.
5. Bager P., Arnved J., Ronborg S., Wohlfahrt J., Poulsen L.K., Westergaard T., Petersen H.W., Kristensen B., Thamsborg S., Roepstorff A., Kapel C., Melbye M. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J. Allergy Clin. Immunol. 2010, 125(123-130):e121-e123.
6. Broadhurst M.J., Leung J.M., Kashyap V., McCune J.M., Mahadevan U., McKerrow J.H., Loke P. IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Sci. Transl. Med. 2010, 2:60ra88.
7. Broadhurst M.J., Ardeshir A., Kanwar B., Mirpuri J., Gundra U.M., Leung J.M., Wiens K.E., Vujkovic-Cvijin I., Kim C.C., Yarovinsky F., Lerche N.W., McCune J.M., Loke P. Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog. 2012, 8:e1003000.
8. Cho I., Blaser M.J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 2012, 13:260-270.
9. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., Collini S., Pieraccini G., Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107:14691-14696.
10. De Luca A., Zelante T., D'Angelo C., Zagarella S., Fallarino F., Spreca A., Iannitti R.G., Bonifazi P., Renauld J.C., Bistoni F., Puccetti P., Romani L. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010, 3:361-373.
11. Elliott D.E., Setiawan T., Metwali A., Blum A., Urban J.F., Weinstock J.V. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur. J. Immunol. 2004, 34:2690-2698.
12. Elliott D.E., Weinstock J.V. Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann. N. Y. Acad. Sci. 2011, 1247:83-96.
13. Finkelman F.D., Shea-Donohue T., Morris S.C., Gildea L., Strait R., Madden K.B., Schopf L., Urban J.F. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 2004, 201:139-155.
14. Fleming J.O., Isaak A., Lee J.E., Luzzio C.C., Carrithers M.D., Cook T.D., Field A.S., Boland J., Fabry Z. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult. Scler. 2011, 17:743-754.
15. Gaze S., McSorley H.J., Daveson J., Jones D., Bethony J.M., Oliveira L.M., Speare R., McCarthy J.S., Engwerda C.R., Croese J., Loukas A. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog. 2012, 8:e1002520.
16. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., Albrecht M., Mayr G., De La Vega F.M., Briggs J., Gunther S., Prescott N.J., Onnie C.M., Hasler R., Sipos B., Folsch U.R., Lengauer T., Platzer M., Mathew C.G., Krawczak M., Schreiber S. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 2007, 39:207-211.
17. Hang L., Setiawan T., Blum A.M., Urban J., Stoyanoff K., Arihiro S., Reinecker H.C., Weinstock J.V. Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J. Immunol. 2010, 185:3184-3189.
18. Hasnain S.Z., Thornton D.J., Grencis R.K. Changes in the mucosal barrier during acute and chronic Trichuris muris infection. Parasite Immunol. 2011, 33:45-55.
19. Hayes K.S., Bancroft A.J., Goldrick M., Portsmouth C., Roberts I.S., Grencis R.K. Exploitation of the intestinal microflora by the parasitic nematode Trichuris muris. Science 2010, 328:1391-1394.
20. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
21. Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J., Jacobson J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 2008, 118:1311-1321.
22. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
23. Jouvin M.H., Kinet J.P. Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis. J Allergy Clin Immunol 2012, 130:3-10.
24. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
25. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
26. Li R.W., Wu S., Li W., Huang Y., Gasbarre L.C. Metagenome plasticity of the bovine abomasal microbiota in immune animals in response to Ostertagia ostertagi infection. PLoS ONE 2011, 6:e24417.
27. Li R.W., Wu S., Li W., Navarro K., Couch R.D., Hill D., Urban J.F. Alterations in the porcine colon microbiota induced by the gastrointestinal nematode Trichuris suis. Infect. Immun. 2012, 80:2150-2157.
28. Mansfield L.S., Gauthier D.T., Abner S.R., Jones K.M., Wilder S.R., Urban J.F. Enhancement of disease and pathology by synergy of Trichuris suis and Campylobacter jejuni in the colon of immunologically naive swine. Am. J. Trop. Med. Hyg. 2003, 68:70-80.
29. McSorley H.J., Gaze S., Daveson J., Jones D., Anderson R.P., Clouston A., Ruyssers N.E., Speare R., McCarthy J.S., Engwerda C.R., Croese J., Loukas A. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS ONE 2011, 6:e24092.
30. Mizoguchi A. Healing of intestinal inflammation by IL-22. Inflamm. Bowel Dis. 2012, 18:1777-1784.
31. Mukhopadhya I., Hansen R., El-Omar E.M., Hold G.L. IBD-what role do Proteobacteria play?. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:219-230.
32. Munoz M., Heimesaat M.M., Danker K., Struck D., Lohmann U., Plickert R., Bereswill S., Fischer A., Dunay I.R., Wolk K., Loddenkemper C., Krell H.W., Libert C., Lund L.R., Frey O., Holscher C., Iwakura Y., Ghilardi N., Ouyang W., Kamradt T., Sabat R., Liesenfeld O. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 2009, 206:3047-3059.
33. Nagalakshmi M.L., Rascle A., Zurawski S., Menon S., de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 2004, 4:679-691.
34. Neufert C., Pickert G., Zheng Y., Wittkopf N., Warntjen M., Nikolaev A., Ouyang W., Neurath M.F., Becker C. Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle 2010, 9:652-655.
35. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
36. Patel N., Kreider T., Urban J.F., Gause W.C. Characterisation of effector mechanisms at the host:parasite interface during the immune response to tissue-dwelling intestinal nematode parasites. Int. J. Parasitol. 2009, 39:13-21.
37. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929-979.
38. Pickert G., Neufert C., Leppkes M., Zheng Y., Wittkopf N., Warntjen M., Lehr H.A., Hirth S., Weigmann B., Wirtz S., Ouyang W., Neurath M.F., Becker C. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 2009, 206:1465-1472.
39. Schulz S.M., Kohler G., Schutze N., Knauer J., Straubinger R.K., Chackerian A.A., Witte E., Wolk K., Sabat R., Iwakura Y., Holscher C., Muller U., Kastelein R.A., Alber G. Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J. Immunol. 2008, 181:7891-7901.
40. Sonnenberg G.F., Fouser L.A., Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011, 12:383-390.
41. Sonnenberg G.F., Monticelli L.A., Alenghat T., Fung T.C., Hutnick N.A., Kunisawa J., Shibata N., Grunberg S., Sinha R., Zahm A.M., Tardif M.R., Sathaliyawala T., Kubota M., Farber D.L., Collman R.G., Shaked A., Fouser L.A., Weiner D.B., Tessier P.A., Friedman J.R., Kiyono H., Bushman F.D., Chang K.M., Artis D. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336:1321-1325.
42. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002, 20:495-549.
43. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A.K., Blumberg R.S., Xavier R.J., Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 2008, 118:534-544.
44. Sun L., Nava G.M., Stappenbeck T.S. Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 2011, 27:321-327.
45. Tachiiri A., Imamura R., Wang Y., Fukui M., Umemura M., Suda T. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun. 2003, 4:153-159.
46. Taylor M.D., van der Werf N., Maizels R.M. T cells in helminth infection: the regulators and the regulated. Trends Immunol. 2012, 33:181-189.
47. van Riet E., Hartgers F.C., Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007, 212:475-490.
48. Walk S.T., Blum A.M., Ewing S.A., Weinstock J.V., Young V.B. Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm. Bowel Dis. 2010, 16:1841-1849.
49. Wescott R.B. Experimental Nematospiroides dubius infection in germfree and conventional mice. Exp. Parasitol. 1968, 22:245-249.
50. Wilson M.S., Feng C.G., Barber D.L., Yarovinsky F., Cheever A.W., Sher A., Grigg M., Collins M., Fouser L., Wynn T.A. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 2010, 184:4378-4390.
51. Witte E., Witte K., Warszawska K., Sabat R., Wolk K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 2010, 21:365-379.
52. Wolff M.J., Broadhurst M.J., Loke P. Helminthic therapy: improving mucosal barrier function. Trends Parasitol. 2012, 28:187-194.
53. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
54. Wolk K., Witte E., Wallace E., Docke W.D., Kunz S., Asadullah K., Volk H.D., Sterry W., Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 2006, 36:1309-1323.
55. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin. Immunopathol. 2010, 32:17-31.
56. Wu S., Li R.W., Li W., Beshah E., Dawson H.D., Urban J.F. Worm burden-dependent disruption of the porcine colon microbiota by Trichuris suis infection. PLoS ONE 2012, 7:e35470.
57. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., Heath A.C., Warner B., Reeder J., Kuczynski J., Caporaso J.G., Lozupone C.A., Lauber C., Clemente J.C., Knights D., Knight R., Gordon J.I. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
58. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
59. Zenewicz L.A., Flavell R.A. Recent advances in IL-22 biology. Int. Immunol. 2011, 23:159-163.
60. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14:282-289.